Valuation
- Market cap
- 13,097,000
- Revenue TTM
- $40,000
- Net income TTM
- $-3,630,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -9,075.00%
- Debt to equity
- 0.03
Trading
- Volume
- 7,200
- Avg volume
- 83,484
- Day's range
- $1.83 – $1.90
- Shares out
- 7,004,000
- Stochastic %K
- 23%
- Beta
- -0.37
- Analysts
- Strong Buy
- Price target
- —
Company profile
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, includi...
Show more
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste streams; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.
- Industry
- Medical Instruments & Supplies
- Sector
- Healthcare
- Phone
- 65 8512 7275
- Website
- https://www.cuprina.com.sg
- Address
- Blk 1090, Lower Delta Road #06-08, Singapore, Singapore
Latest news
No headlines yet.
